TAVI for aortic regurgitation

Session comprising selected EuroPCR 2026 clinical cases submissions

Moderators: O. Soliman, L. Testa

Summary

This session highlights innovative transcatheter aortic valve implantation (TAVI) approaches for treating aortic regurgitation, focusing on off-label uses and complex cases. It features high-risk patient interventions, including nonagenarian patients, and strategies to manage severe non-calcific native valve regurgitation with balloon-expandable valves.

Presentations available when logged in:

  • Keep calm and carry on the implantation
  • Rescue TAVI for decompensated heart failure preserved ejection fraction to severe aortic regurgitation in a high-risk surgical patient
  • Old-school techniques for novel and complex off-label interventions
  • TAVI with balloon-expandable valve in a nonagenarian patient with severe non-calcific native valve aortic regurgitatio
  • Off-label use of a balloon-expandable valve